Lexaria Bioscience Corp. (LEXX)

3.32 +0.12 (+3.75%) USD  |  NASDAQ  |  Oct 09, 16:00
3.57 +0.25 (+7.53%) After-Hours: 20:00
More

Lexaria Bioscience EPS Estimates for Next Fiscal Year

EPS Estimates for Next Fiscal Year Chart

View EPS Estimates for Next Fiscal Year for LEXX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Next Fiscal Year Data

View and export this data back to 2022. Start Trial.
Date Value
January 22, 2024 --
November 30, 2023 --
August 28, 2023 --
June 26, 2023 --
Date Value
April 20, 2023 --
January 17, 2023 --
October 31, 2022 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Fiscal Year Range, Past 5 Years

View EPS Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Fiscal Year Benchmarks

View EPS Estimates for Next Fiscal Year Benchmarks
Start Trial
Target Group, Inc. (Canada) --
InMed Pharmaceuticals, Inc. Upgrade
XORTX Therapeutics, Inc. Upgrade
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade

EPS Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Fiscal Year Upgrade